CSL Behring Aktiebolag
Global biotechnology leader developing innovative therapies for rare and serious diseases.
Oversigt
- 20–49
- Medarbejdere
- 1–5mia SEK
- Omsætning
- 1996
- Grundlagt
Nøglebeslutningstagere
Gordon Naylor
Chief Executive Officer and Managing Director, CSL
Izumi Yoshida
Representative Director and President
Helena Bragd
General Manager, CSL Behring Nordics
Beskrivelse
CSL Behring is a global leader in biotechnology, dedicated to discovering, developing, and delivering innovative therapies for over a century. The company is driven by a core promise to save and improve the lives of people suffering from rare and serious diseases. Their primary focus areas include h...
Tags
Nøgleord
Teknologistak
Virksomhedsoplysninger
- Branche
- Partihandel med medicinsk utrustning och apoteksvaror
- Juridisk form
- Aktiebolag
- Momsnummer
- SE556530197401
Beslutningstagere
3 kontakter i FunnelfeedrGordon Naylor
Chief Executive Officer and Managing Director, CSL
Izumi Yoshida
Representative Director and President
Helena Bragd
General Manager, CSL Behring Nordics
Lignende virksomheder
20 lignende virksomheder i Funnelfeedr
Swedish Orphan Biovitrum AB (publ)
200–499 medarbejdereGlobal biopharma unlocking breakthrough therapies for rare diseases.
Vifor Pharma Nordiska AB
20–49 medarbejdereGlobal leader developing innovative therapies for iron deficiency and kidney disease.
OCTAPHARMA NORDIC AB
5–9 medarbejdereDeveloping and manufacturing life-saving plasma-derived therapies globally.
AMICUS THERAPEUTICS LTD
1–4 medarbejdereGlobal biotechnology company developing transformative medicines for rare diseases.
VIFOR PHARMA NORDISKA AB
Global leader developing innovative therapies for iron deficiency and kidney disease.
Udforsk mere
Spørgsmål om CSL Behring Aktiebolag
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo